tiprankstipranks
YUNGJIN PHARM. CO. LTD (KR:003520)
:003520
South Korea Market
003520
YUNGJIN PHARM. CO. LTD
RESEARCH TOOLSreports

YUNGJIN PHARM. CO. LTD (003520) Financial Statements

― Followers

YUNGJIN PHARM. CO. LTD Financial Overview

YUNGJIN PHARM. CO. LTD's market cap is currently ₩192.04B. The company's EPS TTM is ₩-33.82; its P/E ratio is -31.05; YUNGJIN PHARM. CO. LTD is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 254.26B₩ 252.04B₩ 234.90B₩ 218.38B₩ 196.07B
Gross Profit₩ 75.86B₩ 80.35B₩ 72.59B₩ 64.73B₩ 57.94B
Operating Income₩ 3.42B₩ 8.72B₩ 3.12B₩ -7.36B₩ -13.88B
EBITDA₩ 12.20B₩ 16.87B₩ 7.65B₩ -14.30B₩ -6.56B
Net Income₩ -227.66M₩ 1.23B₩ -3.88B₩ -21.96B₩ -11.58B
Balance Sheet
Cash & Short-Term Investments₩ 28.43B₩ 3.44B₩ 10.21B₩ 682.25M₩ 464.57M
Total Assets₩ 262.38B₩ 234.26B₩ 226.60B₩ 203.08B₩ 194.10B
Total Debt₩ 93.99B₩ 65.08B₩ 66.88B₩ 39.32B₩ 13.06B
Net Debt₩ 65.57B₩ 61.65B₩ 59.67B₩ 38.64B₩ 12.59B
Total Liabilities₩ 170.93B₩ 144.45B₩ 136.97B₩ 113.21B₩ 89.21B
Stockholders' Equity₩ 91.46B₩ 89.80B₩ 89.63B₩ 89.87B₩ 104.89B
Cash Flow
Free Cash Flow₩ -939.92M₩ 133.66M₩ -22.74B₩ -24.81B₩ -2.95B
Operating Cash Flow₩ 10.24B₩ 21.74B₩ -12.50B₩ -11.61B₩ 8.37B
Investing Cash Flow₩ -11.91B₩ -18.30B₩ -13.02B₩ -13.35B₩ -11.64B
Financing Cash Flow₩ 26.65B₩ -7.21B₩ 32.04B₩ 25.18B₩ 3.31B
Currency in KRW

YUNGJIN PHARM. CO. LTD Earnings and Revenue History

Income Statement >

YUNGJIN PHARM. CO. LTD Debt to Assets

Balance Sheet >

YUNGJIN PHARM. CO. LTD Cash Flow

Cash Flow >

YUNGJIN PHARM. CO. LTD Forecast EPS vs Actual EPS

Earnings >